Loading...
KRT13 Antibody

35558

KRT13 Antibody

KRT13 Antibody (catalogue number 35558) is a rabbit-derived primary antibody validated for WB IHC, reactive with Human samples. It targets Keratin, type I cytoskeletal 13 (KRT13): Structural component of intermediate filaments in mucosal stratified squamous epithelia. Supplied as 100ul at ₪1,301.17; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
WB IHC
UniProt ID
P13646
Gene
KRT13
Target organism
Homo sapiens
Catalogue number
35558
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Keratin, type I cytoskeletal 13 (KRT13) · Homo sapiens

Structural component of intermediate filaments in mucosal stratified squamous epithelia. Forms heteropolymers with the type II keratin KRT4, assembling into keratin intermediate filament networks that provides structural integrity and mechanical stability of the mucosal epithelium. Contributes to postnatal tongue mucosal cell homeostasis and tissue organization in response to mechanical stress, potentially through regulation of the G1/S phase cyclins CCNE1 and CCNE2

Tissue specificity: Expressed in some epidermal sweat gland ducts (at protein level) and in exocervix, esophagus and placenta

Sequence length: 458 aa · 49588 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.